The Australian Legal Cannabis Market in 2030!
The Australian market for legal cannabis was worth USD 66.0 million in 2022, and it is projected to grow at an average annual rate of 29.6% from 2023 to 2030.
Examining recent clinical trials on the medical use of cannabis in light of existing legislation.
In the Western world, cannabis has traditionally been seen as a recreational substance. However, the recent approval of certain medicinal products derived from industrial sources and the availability of medical
Reviewing retrospective patient charts: Cannabis usage among individuals with insomnia and sleep disorders.
Medical cannabis has been increasingly used in Canada after being sanctioned by Health Canada in 2001. Insomnia and sleep disorders are among the most common conditions for which patients report
How an Open-Minded General Practitioner Revitalized Senator Peter Whish-Wilson’s Well-being and Salvaged His Political Career with Medicinal Cannabis!
The Green Senator Peter Whish-Wilson went from enduring three years of intense pain, fatigue, brain fog, a gum and ear infection, and a daily battle, contemplating relinquishing his political career
In 2022, around 100,000 Australians were prescribed medicinal cannabis to alleviate chronic pain. Is it effective and when is it Legal to take?
In Australia, chronic pain has become the primary reason for prescribing medicinal cannabis, with over 100,000 prescriptions issued for chronic pain in 2022. Many patients already try various treatment alternatives
Is it permissible to utilize medicinal cannabis for supporting children with autism in Australia?
Parents of children with Autism Spectrum Disorder (ASD) face challenges in finding suitable treatment options. However, there is potential for cannabis oil to offer a solution, as a clinical trial
Has access to medicinal cannabis become excessively convenient since its legalization seven years ago?
As the demand for medical cannabis skyrockets, doctors and advocates share a common worry about the potential impact of commercial interests on patient well-being. Certain patients are essentially being pushed
Patients who are facing unmet mental health needs are increasingly seeking relief through the use of medicinal cannabis.
Data validates the existence of unmet mental health needs among many Australians and highlight the growing trend of medicinal cannabis being explored as an alternative to conventional therapies, stated Dr.
Two Pioneers of Medicinal Cannabis known for challenging and changing public perceptions of Cannabis address the Australian Medicinal Cannabis Symposium.
In August, two renowned figures in the field of medicinal cannabis, who also happen to be the co-founders of Charlotte’s Web, a prominent CBD medicine brand, will be arriving in
Marijuana: 4 Must-Read Articles on the Applications, Effects, and Potential of Cannabis
As several states have legalized marijuana for both medical and recreational use, and federal law permits the sale of hemp-derived products, cannabis, and its derivatives have garnered heightened attention and
Medicinal Cannabis Oil can treat Tourette syndrome!
Australian researchers have made a significant discovery, revealing that medicinal cannabis oil containing a balanced ratio of THC to CBD can effectively alleviate the distressing symptoms commonly associated with Tourette
Why are people using medicinal Cannabis?
The legal use of medicinal cannabis is witnessing a noticeable rise in popularity. The primary reason for the prescribed use of medicinal cannabis aligns with the prescription data from the
Zelira’s share price has experienced a significant surge following a study revealing that their cannabinoid drug has surpassed a multibillion-dollar product by Pfizer in terms of performance.
Zelira Therapeutics, a company listed on the Australian Securities Exchange (ASX), witnessed a remarkable 230% surge in its share price. This surge followed the release of study results demonstrating that
A company based in Burton has entered the race to produce medicinal cannabis in the UK.
A company located in Burton has received approval from the Home Office to grow, process, and package medicinal cannabis for sale in the pharmaceutical industry. About the Author Our
Cantourage UK and CannFX transport first-ever shipment of medical cannabis flower from New Zealand to the UK.
Cantourage UK, a prominent medical cannabis enterprise in Europe, disclosed the debut of the first-ever medical cannabis flower from New Zealand in partnership with the renowned brand CannFX. About
A mother who lost her son to cancer is advocating for better access to medicinal cannabis
The mother who led the campaign to legalize medicinal cannabis in Australia, following her son’s terminal cancer diagnosis, believes that the battle is not yet won and there is still
The legal usage of medical cannabis is increasing in Australia
Recent findings from the Lambert Initiative at the University of Sydney reveal that the majority of Australians still utilize illegal cannabis for medicinal purposes, although there has been a substantial
Can medical cannabis help children with autism in Australia?
Although parents are relieved by the alteration in their children’s behavior, certain hindrances to the treatment persist. About the Author Our deep love of plants and fascination with Cannabis has
Farmer in Victoria Jailed for Growing Huge Medical Marijuana
A man who began cultivating medicinal marijuana on his land to aid in his wife’s epileptic seizures has been sentenced to nearly three years in prison for the cultivation and
The Australian Cannabis Nurses Association has been established to provide education and advocacy for the use of medicinal cannabis.
A recently established group aimed at providing medicinal cannabis education, advocacy, and peer support to nurses has launched this week. About the Author Our deep love of plants and
Vanuatu is preparing to issue licenses for medical cannabis.
Vanuatu is getting ready to grant licenses that will permit companies to cultivate and distribute medical cannabis and hemp across the country. About the Author Our deep love of
Japan’s government is poised to legalize medical marijuana
An outline of bills was revealed indicating that the government is ready to permit the utilization of medical marijuana for treating patients who suffer from incurable illnesses.
A Scientists View on How to Treat Anxiety with Cannabis
Many people are reporting symptoms of anxiety and stress, particularly since the pandemic began. Now a cannabis scientist explains how best to use THC and CBD in treating these disorders.
Pluses and Minuses of Medical Cannabis so Far
This article looks into both the positives and negatives of medicinal cannabis and what evidence has been discovered and researched at the present moment.
Montu Fundraises for ‘Alternaleaf’ Telehealth Services
Montu, a medical group in East Melbourne, Australia, has used crowdfunding platform Birchal to help raise funds for its telehealth services which help patients find doctors who can prescribe medicinal cannabis.
Study Says CBD is Better for Depression than THC
A new study has been published in the Frontiers in Psychiatry journal which has found that cannabis with high amounts of CBD get better results for treating depression than THC-dominant strains.
$33.2 Billion in Medical Cannabis Market Predicted by 2027
The medicinal cannabis market is expected to receive an annual growth rate of 18.4% and to reach around $33.2 billion by the year 2027.
The Use of Medical Cannabis in Australia
This article describes the growing use of medicinal cannabis in Australia, the research behind the drugs and how patients can access the drugs. It also talks about the costs and risks involved.
Those Who Use Cannabis for Chronic Pain Likely to be Younger
The younger generation, aged 18-34 are more likely to use CBD oil to treat conditions such as chronic pain. This figure is double the rate against people who are aged 45 years or over.
MedReleaf to Make Medicinal Cannabis More Affordable
MedReleaf Australia has announced that it plans to make its medicinal cannabis products more accessible to Australians who are in a disadvantaged position, lowering some of their product costs.